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Purpose: The necessity of nasogastric decompression after abdominal surgical procedures has been increasingly questioned 
for several years. Traditionally, nasogastric decompression is a mandatory procedure after classical pancreatico-
duodenectomy (PD); however, we still do not know whether or not it is necessary for PD. The present study was designed to 
assess the clinical benefit of nasogastric decompression after PD. Methods: Between July 2004 and May 2007, 41 consecutive 
patients who underwent PD were enrolled in this study. Eighteen patients were enrolled in the nasogastric tube (NGT) group 
and 23 patients were enrolled in the no NGT group. Results: There were no differences in the demographics, pathology, 
co-morbid medical conditions, and pre-operative laboratory values between the two groups. In addition, the passage of 
flatus (P = 0.963) and starting time of oral intake (P = 0.951) were similar in both groups. In the NGT group, 61% of the patients 
complained of discomfort related to the NGT. Pleural effusions were frequent in the NGT group (P = 0.037); however, other 
post-operative complications, such as wound dehiscence and anastomotic leakage, occurred similarly in both groups. There 
was one case of NGT re-insertion in the NGT group. Conclusion: Routine nasogastric decompression in patients undergoing 
PD is not mandatory because it has no clinical advantages and increases patient discomfort. 
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INTRODUCTION
Nasogastric decompression is routinely used following 
most major intra-abdominal surgeries because it has been 
thought to decrease post-operative ileus, respiratory com-
plications, and the incidence of anastomotic leaks after 
gastrointestinal surgery [1]. In addition, decompression 
may help to prevent distension, and thus might lower the 
risk of wound dehiscence, biliary fistulas, and promote a 
more rapid return of bowel function. Several recent pro-
spective studies have questioned this practice in patients 
who have undergone gastrectomies [2,3] and hepatec-
tomies [4]. Indeed, even more authors have concluded that 
nasogastric decompression is associated with a higher in-Yoon Young Choi, et al.
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cidence of pulmonary complications; therefore, routine 
nasogastric decompression is no longer warranted after 
elective abdominal surgery [5,6]. 
There are no studies that have determined the effect of 
nasogastric decompression in patients undergoing PD. 
Thus, the present study evaluated whether or not nasogas-
tric decompression is necessary in PD patients. 
METHODS
Patient demographics
This study was approved by our Institutional Review 
Board for human investigation of Soonchunhyang 
University Hospital. From July 2004 to May 2007, 41 con-
secutive patients who underwent PD were enrolled in this 
study. After induction of anesthesia, a 16-French nasogas-
tric tube (NGT) was inserted in all patients. In the NGT 
group, the tube remained in place for continuous drainage 
until passage of flatus with a suction pressure of 40 to 50 
mmHg. In the no NGT group, the tube was removed at the 
end of surgery. 
Surgical technique and post-operative care
The standard, pylorus-preserving resection involved 
division of the duodenum 2 cm distal to the pylorus with 
resection of the entire duodenum distal to the transection 
site, removal of the gallbladder and common bile duct 
(proximal to the level of the cystic duct junction), resection 
of the head, neck, and uncinate process of the pancreas 
(underneath the superior mesenteric vein, lateral from the 
mesenteric-portal vein axis, and flush with the superior 
mesenteric artery), and removal of the peri-ampullary 
tumor. For the standard resection, a distal gastrectomy 
varying from 20 to 40% was performed. Frozen section 
was performed routinely at the transection site of the pan-
creatic remnant in all patients. In the case of a macroscopi-
cally-suspicious margin, a frozen section of the margin 
was also performed. 
The technique of pancreatico-jejunal (PJ) anastomosis 
was developed by our department and standardized by 
placing an external pancreatic duct stent for negative suc-
tion drainage of pancreatic juice. In summary, an end- 
to-side, duct-to-mucosa, 2-layer PJ anastomosis was per-
formed using interrupted fine Mexon sutures. The diame-
ter of the pancreatic duct was measured in every case. A 
5-8-French infantile feeding catheter with a single side- 
hole was inserted into the pancreatic duct. The largest size 
stent that could be passed into the pancreatic duct was 
used. Catheter migration was prevented by an anchoring 
stitch that secured the catheter to the mucosa of the jejunal 
side of the PJ anastomosis using double absorbable 
sutures. Care was taken to ensure that there were no 
side-holes in the part of the catheter in the jejunum. The 
catheter exited via a small enterotomy in the opposite site 
of the PJ anastomosis, and was externalized through a stab 
incision in the anterior abdominal wall. The enterotomy 
site for exit of the catheter was closed with a purse-string 
suture, and the serosa around the enterotomy site was su-
tured to the peritoneum of the abdominal wall. Upon com-
pletion of the surgical procedure, negative pressure was 
applied to the pancreatic tubes using a Jackson-Pratt (JP) 
bag. 
After PJ anastomosis, an end-to-side, single layer, inter-
rupted choledochojejunostomy was performed using the 
same jejunal loop with an internal stent. A single layer, 
continuous, hand-sewn antecolic gastrojejunostomy or 
duodenojejunostomy was then performed. No vagoto-
mies, gastrostomies, or feeding jejunostomies were 
performed. At the end of the surgery, drains were left in 
the area of the pancreaticojejunostomy and choledocho-
jejunostomy. One drain was placed anterior to the PJ anas-
tomosis, and another drain was placed posterior to the 
anastomosis (peri-pancreatic drains). 
All patients were managed according to a standard 
post-operative pathway. All patients received histamine 
H2 receptor antagonists as prophylaxis against stress ul-
ceration, and octreotide treatment was continued for 7 
days. The drain was removed if the amylase concentration 
was ＜300 U/L (＜twice the serum concentration) and pro-
duction was ＜50 mL per day or after post-operative day 
10. Patients were allowed sips of water after passage of 
flatus in the absence of symptoms of nausea or distension. 
The diet was advanced in the same stepwise fashion in the 
two groups, from clear liquids to a soft diet as tolerated.  
Demographic data, pathology, co-morbid conditions, Nasogastric decompression in pancreaticoduodenectomy
thesurgery.or.kr 259
NGT group
(n = 18)
No NGT 
group
(n = 23)
P-value
Gender 0.4864
 Male 9            14
 Female 9 9
Mean age (yr) 61.22 ± 11.63 62.61 ± 10.01 0.6841
Pathology 0.7445
 Pancreatic cancer 3 2
 Bile duct cancer 9 9
 Ampullary cancer 4 8
 IPMN 1 3
 Others 1 1
Associated medical 
 condition
 Diabetes mellitus 3 3 0.7446
 Hypertension 3 5 0.6842
 Pulmonary 
    tuberculosis
1 0 0.2524
 Liver cirrhosis 0 1 0.3704
Previous abdominal 
 surgery
2 3 0.8512
Laboratory values
 Mean hemoglobin 
    (g/dL)
 11.6 ± 1.52   12.2 ± 1.52 0.1891
 Mean albumin (g/dL)  3.66 ± 0.50   3.70 ± 0.53 0.8076
 Mean AST (U/L) 105.6 ± 89.48 106.4 ± 104.77 0.7525
a)
 Mean ALT (U/L) 142.6 ± 138.7 117.9 ± 148.65 0.2586
a)
 Mean total bilirubin 
    (mg/dL)
   6.3 ± 5.52     5.2 ± 6.00 0.3012
a)
 Mean CA19-9 (U/mL) 865.7 ± 1,546.9 141.8 ± 289.8 0.0142
a)
a)Mann-Whitney U-test was applied, since the data was failed to 
normality assumption.
NGT, nasogastric tube; IPMN, intraductal papillary mucinous 
neoplasm; AST, aspartic acid transaminase; ALT, alanine 
transaminase; CA 19-9 carbohydrate antigen 19-9.
Table 1. Demographics and general considerations of the patients  pre-operative data, operative variables, and post-oper-
ative complications were recorded. Discomfort related to 
the NGT, expressed subjectively by the patients, was grad-
ed as none, moderate, or severe. 
Definition of various post-operative complications
Pancreatic fistulas were defined according to the criteria 
of the International Study Group on pancreatic fistulas [7]. 
A biliary fistula was diagnosed if there were persistent se-
cretions of bilirubin-rich drainage fluid ＞50 mL per day 
or after the 10th post-operative day. Post-operative bleed-
ing was defined as the need for ＞2 units of red blood cells 
＞24 hours after surgery or re-laparotomy for bleeding. 
Delayed gastric emptying was defined as gastric stasis re-
quiring nasogastric intubation for ＞10 days or the inabil-
ity to tolerate a regular diet on the 14th post-operative day. 
Lung complications, such as pneumonia, atelectasis, and 
pleural effusions, were noted based on chest plain films 
during the post-operative follow-up. 
Statistical analysis
We determined the statistical differences in continuous 
variables by Student’s t-test and the Mann-Whitney U-test 
by checking statistical adequacies. The chi-square test was 
applied for univariate analysis of categorical data, and the 
Poisson linear regression model was applied to test the 
number of events occurring in a fixed period of time be-
tween the NGT and no NGT groups. We used R statistical 
software (version 2.8.0; The R foundation for Statistical 
Computing). We considered values of P ≤ 0.05 statisti-
cally significant.
RESULTS 
The study group included 41 patients (23 males and 18 
females), and the mean age was 62.0 ± 10.63 years. Eigh-
teen patients were enrolled in the NGT group and 23 pa-
tients were enrolled in the no NGT group. The demo-
graphics of each group are shown in Table 1, including 
pathology, co-morbid medical conditions, and previous 
abdominal surgeries. Pre-operative laboratory data were 
compared, and there were no significant differences in 
each group. 
The operative parameters are summarized in Table 2. 
The types of operation, operative time, blood loss, amount 
of transfusion, and size of the pancreatic and common bile 
ducts were not statistically different. There were three cas-
es of combined procedures. A left hepatectomy for an in-
trahepatic duct stone and a lower anterior resection for 
rectal cancer were performed in the NGT group, and a 
right adrenalectomy for a right adrenal mass was per-
formed in the no NGT group. The post-operative courses 
are summarized in Table 3. The mean duration of time the 
NGT remained in place was 4.28 ± 3.24 days. The mean 
hospital stay, time to passage of flatus, and time to start a Yoon Young Choi, et al.
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NGT group
(n = 18)
No NGT 
group
(n = 23)
P-value
Name of operation 0.1848
   Whipple’s operation 15 16
   PPPD   1   6
   Combined operation   2   1
Other operative 
  parameters
   Mean operation time 
     (min)
503.3 ± 88.0    528.3 ± 112.52 0.4446
   Mean blood loss (mL)  922.2 ± 357.37 1,178.3 ± 506.28 0.1158
a)
   Mean P-duct size (mm)   3.77 ± 2.53      4.22 ± 2.26 0.6932
a)
   Mean CBD size (mm)   15.1 ± 5.54      15.3 ± 6.52  0.8651
   Blood transfusion (unit) 253.9 ± 295.32    185.2 ± 560.66 0.05221
a)
a)Mann-Whitney U-test was applied, since the data was failed to 
normality assumption.
NGT, nasogastric tube; PPPD, pylorus preserving pancreatico-
duodenectomy; CBD, common bile duct.
Table 2. Parameters related to operation
Table 3. Postoperative course
NGT group 
(n = 18)
No NGT 
group 
(n = 23)
P-value
Duration of gastric 
  decompression (day)
  4.28 ± 3.24 - NA
Time to first passage of flatus 
  (day)
  4.89 ± 1.32   4.87 ± 1.29 0.978
a)
Time to first oral intake (day)   8.67 ± 5.01   8.74 ± 2.32 0.938
a)
Mean hospital days 26.11 ± 11.7 25.78 ± 9.87 0.838
a)
Discomfort related to the NGT
    None 7 (39)
    Moderate 5 (28)
    Severe 6 (33)
Values are presented as mean ± SD or number (%).
NGT, nasogastric tube; NA, not available.
a)Test by Poisson linear regression model.
Table 4. Postoperative complications
NGT group 
(n = 18)
No NGT 
group 
(n = 23)
P-value
Overall complications 16 20 0.8512
Urinary complications   2   3 0.8510
Lung complications 15 17 0.4696
　Atelectasis 13 13 0.3003
   Pleural effusion 15 12 0.0368
　Pneumonia   2   1 0.4092
Intra-abdominal complications   4   4 0.6895
   PJ leakage   2   2 0.7959
   CJ leakage   1   2 0.7016
   GJ leakage   1   0 0.2524
   Intra-abdominal abscess   2   4 0.5723
Delayed gastric emptying   1   0 0.2524
Wound complications   3 10 0.0671
   Seroma   3 10 0.0671
   Infection   1   2 0.7016
   Dehiscence   1   3 0.4226
NGT, nasogastric tube; PJ, pancreatico-jejunostomy; CJ, choledo-
cho-jejunostomy; GJ, gastro-jejunostomy.
liquid diet were not statistically different between the two 
groups. However, 11of 18 patients (61%) complained of 
discomfort from the NGT tube. 
The post-operative complications are compared in 
Table 4. There were two PJ leakages (Bassi type B) in each 
group. Most of the complications occurred with similar in-
cidences, with the exception of pleural effusions. The rate 
of total lung complications, atelectasis, and pneumonia 
were not significantly different, but pleural effusions oc-
curred more frequently in the NGT group than the no 
NGT group (P = 0.037). Delayed gastric emptying occurred 
in one patient in the NGT group, who underwent NGT 
re-insertion. Fortunately, there were no mortalities. The in-
tra-abdominal abscess was controlled by percutaneous 
drainage and each leak was controlled by conservative 
treatment such as NPO. 
DISCUSSION
After Levin [8] introduced nasogastric intubation, and 
Wangensteen and Paine [9] popularized its use in the treat-
ment of acute intestinal obstruction and post-operative 
ileus, many surgeons have subscribed to the unproven be-
lief that a NGT is beneficial following most major intra-ab-
dominal procedures and decreases post-operative compli-
cations, such as vomiting, wound dehiscence, and anasto-
motic leaks. Recently, however, several studies have re-
ported opposite results. Some authors have reported that 
insertion of a NGT had no effect on the return of bowel 
function, as noted previously for other abdominal proce-
dures [6], and other authors have shown this time to be sig-Nasogastric decompression in pancreaticoduodenectomy
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nificantly longer in patients with an NGT, probably owing 
to delayed or decreased ambulation [10]. Also, prospec-
tive studies in Taiwan [11] and Korea [3,12] with high-case 
volumes have also suggested that there is no need for an 
NGT following gastrectomy for gastric cancer. In our 
study, there was no difference in the time to passage of 
flatus and resumption of a liquid diet; thus, NGT had no 
clinical benefit on the early return of bowel function and 
early advancement of diet. 
In a prospective randomized trial, Pessaux et al. [4] re-
ported that although an NGT was effective in preventing 
vomiting following hepatic resection, the NGT had no ef-
fect on the incidence of nausea and its use was associated 
with an increased risk of pneumonia. As Cheatham et al. 
[5] suggested, the interval to first oral intake was sig-
nificantly less, and the incidence of pulmonary complica-
tions and post-operative fevers were significantly lower in 
patients managed without NGTs, whereas routine naso-
gastric decompression did not decrease the incidence of 
any other complications. Other studies [13,14] have shown 
the presence of an NGT to be an independent risk factor for 
increased post-operative pulmonary complications; spe-
cifically, the NGT may interfere with an effective cough 
through incomplete closure of the glottis, leading to the ac-
cumulation of secretions that increase the risk of ate-
lectasis and infection, and bacteria may be transferred 
more easily from the oropharynx to the lungs, thus in-
creasing the risk of respiratory infections. In our cases, 
pleural effusions occurred more frequently in the NGT 
group more than the no NGT group, but there were no dif-
ferences in atelectasis or pneumonia and the total in-
cidence of lung complications. Also, it appeared that NGT 
insertion did not reduce anastomotic leaks and wound 
complications, such as dehiscence. Although not statisti-
cally significant, delayed gastric emptying occurred in one 
patient in the NGT group who needed re-insertion of the 
NGT. 
Some studies have reported other complications, such 
as injuries to the larynx [15], esophagitis [16], pharyngitis, 
otitis, electrolytic losses, aerophagia, or rhinosinusitis [17] 
induced by NGT insertion. In our cases, 61% of the NGT 
group patients complained of discomfort due to the NGT 
and 33% of patients felt severe discomfort related to the 
NGT. 
In conclusion, the routine insertion of a NGT in patients 
who have undergone a PD has no advantages with respect 
to post-operative complications and it can increase the 
post-operative pulmonary complications. Also, it appears 
that NGT insertion cause patient’s discomfort after 
operation. Therefore, routine NGT insertion needs to be 
reconsidered in patients who undergo PD. 
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